Altered phenotype of regulatory T cells associated with lack of human immunodeficiency virus (HIV)-1-specific suppressive function
- 10 October 2011
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 166 (2) , 191-200
Abstract
Summary: Mechanisms by which CD4+ regulatory T cells (Tregs) mediate suppression of virus-specific responses remain poorly defined. Adenosine, mediated via CD39 and CD73, has been shown to play a role in the action of murine Tregs. In this study we investigate the phenotype of Tregs in the context of human immunodeficiency virus (HIV)-1 infection, and the function of these cells in response to HIV-1-Gag and cytomegalovirus (CMV) peptides. Phenotypic data demonstrate a decrease in forkhead box transcription factor 3 (FoxP3+) Treg numbers in the peripheral blood of HIV-1+ individuals compared to healthy controls, which is most pronounced in those with high HIV-1 RNA plasma load. Due to aberrant expression of CD27 and CD127 during HIV-1 disease, these markers are unreliable for Treg identification. The CD3+CD4+CD25hiCD45RO+ phenotype correlated well with FoxP3 expression in both the HIV-1+ and seronegative control cohorts. We observed expression of CD39 but not CD73 on Tregs from HIV-1+ and healthy control cohorts. We demonstrate, through Treg depletion, the suppressive potential of Tregs over anti-CMV responses in the context of HIV-1 infection; however, no recovery of the HIV-1-specific T cell response was observed indicating a preferential loss of HIV-1-specific Treg function. We propose that before immunotherapeutic manipulation of Tregs is considered, the immunoregulatory profile and distribution kinetics of this population in chronic HIV-1 infection must be elucidated fully.Keywords
This publication has 48 references indexed in Scilit:
- Phenotypical and functional specialization of FOXP3+ regulatory T cellsNature Reviews Immunology, 2011
- IL-2 Immunotherapy to Recently HIV-1 Infected Adults Maintains the Numbers of IL-17 Expressing CD4+ T (TH17) Cells in the PeripheryJournal of Clinical Immunology, 2010
- In vivo expansion of naive and activated CD4 + CD25 + FOXP3 + regulatory T cell populations in interleukin-2–treated HIV patientsProceedings of the National Academy of Sciences, 2010
- Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individualsClinical and Experimental Immunology, 2009
- HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppressionInternational Immunology, 2009
- Level, phenotype and activation status of CD4+FoxP3+ regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virusClinical and Experimental Immunology, 2008
- Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppressionJournal of Experimental Medicine, 2007
- Cyclic adenosine monophosphate is a key component of regulatory T cell–mediated suppressionJournal of Experimental Medicine, 2007
- CD39/NTPDase-1 activity and expression in normal leukocytesThrombosis Research, 2007
- Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cellsJournal of Experimental Medicine, 2006